Ā | Univariate | Multivariable | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
Elixhauser Comorbidity Indexa | ||||||
āNo Comorbidity (Scoreā=ā0) | ref | Ā | Ā | Ā | Ā | Ā |
āAny Comorbidity (Scoreāā„ā1) | 1.10 | [0.77,1.56] | 0.61 | Ā | Ā | Ā |
Diabetesa | ||||||
āNo | ref | Ā | Ā | ref | Ā | Ā |
āYes | 5.46 | [1.57,18.94] | 0.008 | 7.27 | [1.93,27.30] | 0.003 |
Hypertensiona | ||||||
āNo | ref | Ā | Ā | Ā | Ā | Ā |
āYes | 1.29 | [0.84,1.19] | 0.37 | Ā | Ā | Ā |
Liver Diseasea | ||||||
āNo | ref | Ā | Ā | Ā | Ā | Ā |
āYes | 1.05 | [0.50,2.21] | 0.90 | Ā | Ā | Ā |
HIVa | ||||||
āNo | ref | Ā | Ā | Ā | Ā | Ā |
āYes | 0.73 | [0.16,3.28] | 0.68 | Ā | Ā | Ā |
Screening Test | ||||||
āTuberculin Skin Test | ref | Ā | Ā | Ā | Ā | Ā |
āInterferon Gamma Release Assay | 1.21 | [0.80,1.84] | 0.37 | Ā | Ā | Ā |
Year of Arrival | ||||||
ā2012 | ref | Ā | Ā | Ā | Ā | Ā |
ā2013 | 1.50 | [0.93,2.41] | 0.10 | Ā | Ā | Ā |
ā2014 | 1.32 | [0.79,2.18] | 0.29 | Ā | Ā | Ā |
ā2015 | 1.12 | [0.66,1.89] | 0.67 | Ā | Ā | Ā |
ā2016 | 0.99 | [0.58,1.70] | 0.97 | Ā | Ā | Ā |
Family Size at Time of Entry | ||||||
āSingle | ref | Ā | Ā | ref | Ā | Ā |
āFamily of 2ā3 | 1.36 | [0.89,2.07] | 0.16 | 1.18 | [0.74,1.87] | 0.49 |
āFamily ofā>ā3 | 1.05 | [0.71,1.56] | 0.80 | 1.11 | [0.70,1.74] | 0.66 |
Sex | ||||||
āFemale | ref | Ā | Ā | ref | Ā | Ā |
āMale | 1.01 | [0.72,1.43] | 0.06 | 1.02 | [0.74,1.49] | 0.90 |
Region of Origin | ||||||
āSub-Saharan Africa | ref | Ā | Ā | ref | Ā | Ā |
āSouth-eastern Asia | 2.10 | [1.34,3.29] | 0.001 | 2.30 | [1.43,3.70] | 0.001 |
āSouthern Asia | 1.63 | [1.05,2.58] | 0.03 | 1.64 | [1.02,2.64] | 0.04 |
āWestern Asia | 0.88 | [0.44,1.77] | 0.72 | 0.64 | [0.29,1.38] | 0.25 |
āOther | 2.00 | [0.84,4.79] | 0.12 | 2.33 | [0.92,5.94] | 0.08 |
Smoking History | ||||||
āNo | ref | Ā | Ā | Ā | Ā | Ā |
āYes | 0.92 | [0.47,1.79] | 0.80 | Ā | Ā | Ā |
Flu Shot Received | ||||||
āNo | ref | Ā | Ā | ref | Ā | Ā |
āYes | 1.51 | [1.08,2.12] | 0.02 | 1.65 | [1.14,2.40] | 0.008 |
Regimen | ||||||
ā9H: Isoniazid only | ref | Ā | Ā | ref | Ā | Ā |
ā3HP: Isoniazidā+āRifapentine | 1.33 | [.087,2.04] | 0.19 | 1.58 | [0.99,2.51] | 0.05 |
ā4R: Rifampin | 1.49 | [0.47,4.79] | 0.50 | 1.47 | [0.42,5.10] | 0.54 |
āMultiple regimens | 1.65 | [0.75,3.61] | 0.21 | 1.54 | [0.68,3.47] | 0.30 |
Time to Appointment, days | ||||||
āScreened after 11 vs 28ādays | 0.49 | [0.28,0.86] | 0.01 | 0.47 | [0.26,0.86] | 0.01 |
āScreened after 14 vs 28ādays | 0.61 | [0.41,0.91] | 0.01 | 0.48 | [0.27,0.86] | 0.01 |
Distance to TB Clinic, miles | 0.92 | [0.82,1.03] | 0.16 | Ā | Ā | Ā |
Ageb | 1.00 | [0.99,1.01] | 0.79 | 1.00 | [0.99,1.02] | 0.63 |